The primary objective of the Hemostasis GRC/GRS is to advance the understanding of blood coagulation, platelet biology, anticoagulant pathways, and associated diseases. Such advances are critical since, despite past successes, thrombotic diseases are still major contributors to human mortality and morbidity. First organized by hemostasis pioneers Earl W. Davie and Oscar Ratnoff in 1973, the Hemostasis GRC is widely considered as the premier, small-format scientific meeting in the field. The Hemostasis GRC brings together a community of investigators interested in the biology, biochemistry, and genetics of platelets and coagulation proteins; physicians involved in the treatment of bleeding and thrombotic diseases; and scientists from small and large pharmaceutical/biotechnology companies developing new therapeutics and diagnostics for hemostatic disorders. The sustained impact of this long-running conference on the field has been remarkable. A series of spectacular achievements in the area debuted at past GRCs. The small size of the conference, quality of speakers and participants, and informal settings for discussion of new and unpublished findings have provided a profoundly stimulating environment for leaders in the field and young investigators alike.
The conference will consist of nine sessions, on the topics listed below. The conference chair is currently developing their preliminary program, which will include the names of the invited speakers and discussion leaders for each of these sessions. The preliminary program will be available by October 15, 2019. Please check back for updates.
- Coagulation: Signaling and Structure
- Coagulation and Platelets in Inflammation
- Maintaining Hemostatic Balance
- Clots and DVT Structure
- Lessons of Molecular Hemostasis from Organisms that Feed on Blood
- Coagulation and Platelets in Chronic Diseases
- Late-Breaking Topics
- Bleeding and Clotting Control
- Keynote Session: Von Willebrand Factor and Kindlins in Bleeding Disorders